| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 02/27/2007 | US7183299 Tetrazoyl oxime derivative and agricultural chemical containing the same as active ingredient |
| 02/27/2007 | US7183297 For therapy of rheumatoid arthritis, osteoarthritis, asthma, psoriasis, eczema, allergic rhinitis, allergic conjunctivitis, adult respiratory distress syndrome, chronic pulmonary inflammation, chronic obstructive pulmonary disease, chronic heart failure, silicosis, endotoxemia, toxic shock syndrome |
| 02/27/2007 | US7183296 Anti-HIV pyrazole derivatives |
| 02/27/2007 | US7183295 Compound for treatment of lipemic agents, antiinflammatory agents and treatment of diabetes |
| 02/27/2007 | US7183294 Indole derivatives useful for the treatment of diseases |
| 02/27/2007 | US7183290 Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 02/27/2007 | US7183288 2-phenylamino-4-pyrimidinecarboxamides; coupling a phenylamine with a halopyrimidine, or coupling a halobenzene with an aminopyrimidine, or amidating the 2-phenylamino-4-pyrimidylacylhalide, or oxidizing the 2-phenylamino-4-cyanopyrimidine |
| 02/27/2007 | US7183287 Substituted pyrimidinones |
| 02/27/2007 | US7183286 Compounds, methods and compositions useful for the treatment of bovine viral diarrhea virus (BVDV) infection and hepatitis C virus (HCV) infection |
| 02/27/2007 | US7183283 5-{2-[4-[1-(4-fluoro-2-hydroxy-phenyl)-methanoyl]-piperidine-1-yl]-(ethyl or propyl)amino}-(optional 2-alkyl)-2H-pyridazine-3-one; hydrogenation of the isoxazolyl-alkylamino-pyridazinone; anxiolytic agents |
| 02/27/2007 | US7183281 Sulfonylquinoxalone derivatives and related compounds as bradykinin antagonists |
| 02/27/2007 | US7183278 (Halo)alkoxy-3-(alkoxy or alkanoyl)-N-alkylene picolinamide; reacting a picolinic acid, ester or acyl halide with a primary amine; agricultural fungicides; rice blast, cucumber anthracnose, powdery mildew of cucumber and wheat leaf rust |
| 02/27/2007 | US7183277 Alpha-((aryl or heteroaryl)ureido or carbamoyloxy)-N-heteroaryl amides; blood-coagulation factor Xa and VIIa inhibitors; synergistic mixtures with other antitumor agents or anticoagulants |
| 02/27/2007 | US7183274 Piperidine-2,6-diones heterocyclically substituted in the 3-position |
| 02/27/2007 | US7183273 Administering compounds such as N-(2-pyridinylmethyl)-N'-(6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-9-yl)-1,4-benzenedimethanamine for therapy of disease mediated by a chemokine receptor |
| 02/27/2007 | US7183270 Cyclic derivatives as modulators of chemokine receptor activity |
| 02/27/2007 | US7182953 Methods and compositions for the prevention and treatment of atherosclerosis restenosis and related disorders |
| 02/23/2007 | WO2007021308A1 Metabotropic glutamate-receptor-potentiating isoindolones |
| 02/22/2007 | WO2007022280A1 Phosphodiesterase 10 inhibitors |
| 02/22/2007 | WO2007022165A2 Factor xa inhibitor inclusion complex with cyclodextrin |
| 02/22/2007 | WO2007021803A1 Compounds for the treatment of inflammatory disorders |
| 02/22/2007 | WO2007021794A1 Substituted imidazole compounds as ksp inhibitors |
| 02/22/2007 | WO2007021711A2 Substituted-3-sulfonylindazole derivatives as 5-hydroxytryptamine-6 ligands |
| 02/22/2007 | WO2007021573A1 Substituted piperazines as metabotropic glutamate receptor antagonists |
| 02/22/2007 | WO2007021464A1 Hindered cyclic polyamines and their salts for acid gas scrubbing process |
| 02/22/2007 | WO2007021309A1 Substituted isoindolones and their use as metabotropic glutamate receptor potentiators |
| 02/22/2007 | WO2007020888A1 Brain/neuronal cell-protecting agent, and therapeutic agent for sleep disorder |
| 02/22/2007 | WO2007020877A1 Anthranilamide compounds, process for producing these, and pest control agent comprising any of these |
| 02/22/2007 | WO2007020652A1 Aminoaryl sulphonamide derivatives as functional 5-ht6 ligands. |
| 02/22/2007 | WO2007020502A2 Cannabinoid receptor ligands and uses thereof |
| 02/22/2007 | WO2007020426A1 Pyrazolone derivatives for the treatment of tuberculosis |
| 02/22/2007 | WO2007020411A1 Amide derivatives |
| 02/22/2007 | WO2007020388A1 Pyrazole derivatives as therapeutic agents |
| 02/22/2007 | WO2007020365A1 The ocean wave energy converter (owec) |
| 02/22/2007 | WO2007020261A2 Selected cgrp antagonists, methods for the production thereof and their use as medicaments |
| 02/22/2007 | WO2007020194A1 Piperidine and piperazine derivatives as p2x3 antagonists |
| 02/22/2007 | WO2007020190A1 Fluoro substituted 2-oxo azepan derivatives |
| 02/22/2007 | WO2007020046A1 Benzoquinazoline derivatives and their use in treating bone disorders |
| 02/22/2007 | WO2007019867A1 Novel 2,3-dihydroindole compounds |
| 02/22/2007 | WO2007002764A3 Di-substituted oxadiazoles as cxc-chemokine receptor ligands |
| 02/22/2007 | WO2007000550A3 Novel indoline compounds |
| 02/22/2007 | WO2006133006A3 1-methyl-1h-pyrazole-4-carboxamides useful as cancer chemotherapeutic agents |
| 02/22/2007 | WO2006130736A3 High quantum yield acridinium compounds and their uses in improving assay sensitivity |
| 02/22/2007 | WO2006127379A3 Par2-modulating compounds and their use |
| 02/22/2007 | WO2006084186A3 Compounds comprising linked hetero aryl moieties and their use as novel umami flavor modifiers, tastants and taste enhancers for comestible compositions |
| 02/22/2007 | WO2006071130A8 A process for preparation of imatinib base |
| 02/22/2007 | WO2005089511A3 Novel pharmaceutical forms, and methods of making and using the same |
| 02/22/2007 | US20070043084 1,2-Diarylimidazoles useful as inhibitors of cox |
| 02/22/2007 | US20070043081 N-Cyclopropyl-N-(1-{2-[3-(2,6-dimethyl-pyridin-4-yl)-ureido]-ethyl}-piperidin-4-yl)-2-fluoro-benzenesulfonamide; 2-(4-Chloro-phenyl)-N-(1-{2-[3-(2,6-dimethyl-pyridin-4-yl)-ureido]-ethyl}-piperidin-4-yl)-N-methyl-acetamide; neurohormonal antagonists |
| 02/22/2007 | US20070043080 Substituted anilinic piperidines as MCH selective antagonists |
| 02/22/2007 | US20070043078 Angiogenesis inhibitor |
| 02/22/2007 | US20070043065 Amide derivatives |
| 02/22/2007 | US20070043056 5-Substituted-2-arylpyrazines |
| 02/22/2007 | US20070043053 for treating p38 kinase-associated conditions like inflammatory disorders; improved dissolution rate and oral bioavailability; rheumatic diseases; skin disorders; multiple sclerosis; osteoporosis; Alzheimer's disease |
| 02/22/2007 | US20070043051 Methods and compositions of novel triazine compounds |
| 02/22/2007 | US20070043049 Substituted heterocyclic diarylamine analogues |
| 02/22/2007 | US20070043043 Benzimidazole derivates: preparation and pharmaceutical applications |
| 02/22/2007 | US20070043042 Quinoline potassium channel inhibitors |
| 02/22/2007 | US20070043040 Inhibitors of akt (protein kinase b) |
| 02/22/2007 | US20070043037 Pyrimidine derivatives as orexin receptor antagonists |
| 02/22/2007 | US20070043036 2-Pyridone derivatives as neutrophil elastase inhibitors and their use |
| 02/22/2007 | US20070043019 Salt and crystalline forms thereof of a drug |
| 02/22/2007 | US20070043010 Quinazoline derivatives |
| 02/22/2007 | US20070043009 Quinazoline derivatives as tyrosine kinase inhibitors |
| 02/22/2007 | US20070043001 Cancer; 1-(1-{4-[5-(5-amino-1,3,4-thiadiazol-2-yl)-3-phenylpyridin-2-yl]benzyl}piperidin-4-yl) -1H-pyrazolo[3,4-d]pyrimidin-4-amine; serine/threonine kinase (Akt) suppression; increased cellular potency or solubility, enhanced pharmacokinetic properties |
| 02/22/2007 | US20070042935 Quinazolinone-derivatives and their use for preparation of pharmaceutical compositions having parp enzyme inhibitory effect |
| 02/22/2007 | DE69530936C5 Boronsäure-und-esterverbindungen, deren systhese und verwendungen Boronic acid and ester compounds whose systhese and uses |
| 02/22/2007 | DE102005038831A1 New N-acylalkoxycarbonyl-piperidine derivatives, useful as CGRP antagonists, for treating e.g. headaches, cardiovascular disease, skin disorders, morphine tolerance, and inflammatory diseases such as osteoarthritis and allergic rhinitis |
| 02/22/2007 | CA2750864A1 Bis-aryl amide compounds and methods of use |
| 02/22/2007 | CA2619706A1 Novel high affinity quinoline-based kinase ligands |
| 02/22/2007 | CA2619462A1 Phosphodiesterase 10 inhibitors |
| 02/22/2007 | CA2619407A1 Bicyclic bisamide derivatives and use thereof as insecticides |
| 02/22/2007 | CA2619262A1 Pyrazolone derivatives for the treatment of tuberculosis |
| 02/22/2007 | CA2619249A1 Benzoquinazoline derivatives and their use in treating bone disorders |
| 02/22/2007 | CA2619228A1 Pyrazole derivatives as therapeutic agents |
| 02/22/2007 | CA2619223A1 Fluoro substituted 2-oxo azepan derivatives |
| 02/22/2007 | CA2619010A1 Substituted-3-sulfonylindazole derivatives as 5-hydroxytryptamine-6 ligands |
| 02/22/2007 | CA2618834A1 Selected cgrp antagonists, methods for the production thereof and their use as medicaments |
| 02/22/2007 | CA2618747A1 Substituted imidazole compounds as ksp inhibitors |
| 02/22/2007 | CA2618679A1 Compounds for the treatment of inflammatory disorders |
| 02/22/2007 | CA2618653A1 Brain/neuronal cell-protecting agent and therapeutic agent for sleep disorder |
| 02/22/2007 | CA2618451A1 Amide derivatives |
| 02/22/2007 | CA2618340A1 Piperidine and piperazine derivatives as p2x3 antagonists |
| 02/22/2007 | CA2616307A1 Substituted piperazines as metabotropic glutamate receptor antagonists |
| 02/22/2007 | CA2614864A1 The ocean wave energy converter (owec) |
| 02/21/2007 | EP1754703A2 N-Heterocyclic derivatives as nos inhibitors |
| 02/21/2007 | EP1753763A2 Indazole and indolone derivatives and their use as pharmaceuticals |
| 02/21/2007 | EP1753758A1 Mercaptoimidazoles as ccr2 receptor antagonists |
| 02/21/2007 | EP1753757A1 Substituted 2,5-diaminomethyl-1h-pyrroles |
| 02/21/2007 | EP1753749A1 Novel indole derivatives as selective androgen receptor modulators (sarms) |
| 02/21/2007 | EP1753748A1 Proline derivatives and their use as dipeptidyl peptidase iv inhibitors |
| 02/21/2007 | EP1753745A2 Pyrazinylmethyl lactam derivatives |
| 02/21/2007 | EP1753743A1 Pyridazinone derivatives, methods for producing them and their use as pharmaceuticals |
| 02/21/2007 | EP1753742A2 Magnesium complexes of s-omeprazole |
| 02/21/2007 | EP1753741A1 Crystalline forms of (+) and (-)-erythro-mefloquine hydrochloride |
| 02/21/2007 | EP1753740A2 Amino cyclopentyl heterocyclic and carbocyclic modulators of chemokine receptor activity |
| 02/21/2007 | EP1753739A1 Imidazol-2-one compounds useful in the treatment of various disorders |
| 02/21/2007 | EP1753738A1 Pyrrole compounds as inibitors of erk protein kinase, synthesis thereof and intermediates thereto |
| 02/21/2007 | EP1753731A2 Pyrimidin-4-one derivatives and their use as p38 kinase modulators |
| 02/21/2007 | EP1753730A1 Dipeptidyl peptidase inhibitors |